Literature DB >> 2395408

Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy.

L V Johansen1, J Overgaard, M Overgaard, N Birkler, A Fisker.   

Abstract

Radiotherapy was administered to 213 consecutively treated patients with oropharyngeal squamous cell carcinoma. The classification (Union Internationale Contre le Cancer, 1982) showed primary tumors (T1, 13%; T2, 51%; T3, 34%; T4, 2%) and regional lymph nodes (N0, 38%; N1, 38%; N2, 4%; N3, 20%). The 10-year actuarial value for local control was 48%; for regional control, it was 66%. Distant failure occurred in 20 patients. The 10-year actuarially corrected survival rate was 40% (stage I, 57%; stage II, 51%; stage III, 43%; stage VI, 21%). Locoregional tumor control was significantly influenced by irradiation parameters (total dose and treatment time), tumor volume, sex, and hemoglobin value. It is concluded that local control of the tumor while still in the T position is the parameter most crucial to success. This end point is currently being aimed at evaluating primary surgery and testing a radiation technique with larger total doses and shrinking fields and a new radiosensitizer, while at the same time investigating the influence of hemoglobin concentration.

Entities:  

Mesh:

Year:  1990        PMID: 2395408     DOI: 10.1288/00005537-199009000-00012

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Tonsillar carcinoma: A review.

Authors:  G Mankekar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2002-01

2.  The oral tumours of two American presidents: what if they were alive today?

Authors:  A Renehan; J C Lowry
Journal:  J R Soc Med       Date:  1995-07       Impact factor: 5.344

3.  T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study.

Authors:  Alain Cosmidis; Jean-Pierre Rame; Olivier Dassonville; Stéphane Temam; François Massip; Gilles Poissonnet; Marc Poupart; Patrick Marandas; Dominique De Raucourt
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

4.  Tonsillar carcinoma.

Authors:  M E Guay; P Lavertu
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  A nationwide study of the epidemiology, treatment and survival of oropharyngeal carcinoma in The Netherlands.

Authors:  S Mak-Kregar; F J Hilgers; P C Levendag; J J Manni; H Lubsen; J L Roodenburg; J M van der Beek; A G van der Meij
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.